elmug4future 2025
CMOS-basierte Sensorsysteme für die In-vitro-Diagnostik (CMOS-based sensor systems for in-vitro diagnostics)
Alexander Hofmann, Benjamin Saft, Eric Schäfer
IMMS develops and researches sensor systems for in-vitro diagnostics with CMOS-based biosensors as their core technology. The aim is to develop bioanalytical applications for individual, decentralised health monitoring with electronic rapid tests, among other things. Thematically, the R&D work is divided into optical and electrochemical CMOS biosensors, which will be presented in the talk.
The focus of the electrochemical CMOS biosensors is on the development of miniaturised, potentiometric pH sensors, so-called ion-sensitive field-effect transistors (ISFETs), which are manufactured in a cost-effective, mass-compatible standard CMOS process.
With optical CMOS biosensors, the focus is on the development of specialised image sensors with lock-in technology for the detection of weak fluorescence signals. In particular, these sensors enable time-resolved fluorescence (TRF) measurement and are suitable for applications in which conventional CMOS sensors reach their sensitivity limits.
This might also be interesting for you
Contact
Contact
Dipl.-Hdl. Dipl.-Des. Beate Hövelmans
Head of Corporate Communications
beate.hoevelmans(at)imms.de+49 (0) 3677 874 93 13
Beate Hövelmans is responsible for the text and image editorial work on this website, for the social media presence of IMMS on LinkedIn and YouTube, the annual reports, for press and media relations with regional and specialist media and other communication formats. She provides texts, photographs and video material for your reporting on IMMS, arranges contacts for interviews and is the contact person for events.